T. Rowe Price Associates’s Allergan plc. AGN.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-42,876
| Closed | -$25.1M | – | 2597 |
|
|
2017
Q4 | $25.1M | Sell |
42,876
-31,128
| -42% | -$18.2M | ﹤0.01% | 1100 |
|
|
2017
Q3 | $53.9M | Buy |
74,004
+740
| +1% | +$539K | 0.01% | 816 |
|
|
2017
Q2 | $63.2M | Sell |
73,264
-14,951
| -17% | -$12.9M | 0.01% | 749 |
|
|
2017
Q1 | $74.4M | Sell |
88,215
-573
| -0.6% | -$483K | 0.01% | 680 |
|
|
2016
Q4 | $66.5M | Hold |
88,788
| – | – | 0.01% | 717 |
|
|
2016
Q3 | $72.5M | Sell |
88,788
-848
| -0.9% | -$692K | 0.01% | 677 |
|
|
2016
Q2 | $74M | Sell |
89,636
-148,820
| -62% | -$123M | 0.02% | 658 |
|
|
2016
Q1 | $220M | Sell |
238,456
-141,514
| -37% | -$130M | 0.05% | 377 |
|
|
2015
Q4 | $388M | Sell |
379,970
-172,900
| -31% | -$177M | 0.08% | 255 |
|
|
2015
Q3 | $513M | Buy |
552,870
+4,045
| +0.7% | +$3.76M | 0.11% | 202 |
|
|
2015
Q2 | $570M | Buy |
+548,825
| New | +$570M | 0.12% | 198 |
|